N-Sorb leverages Aptar CSP Technologies’ proven 3-Phase Activ-Polymer™ platform technology to address the pressing issue of N-nitrosamine impurities in pharmaceuticals.
Blister Packaging for Certain Immediate Release Opioid Analgesics for Treatment of Acute Pain – Docket No. FDA-2019-N-1845 as it relates to opioid packaging, and recently passed Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients (SUPPORT) Act, passed in late 2018.
MonoSol Rx LLC, a specialty pharmaceutical company, and MonoSol LLC, the Kuraray Company’s water-soluble film division, announce an agreement through which MonoSol LLC will receive a perpetual license to MonoSol Rx’s intellectual property.
